Wellness is a legitimate term but a wellness journey requires a long-term commitment from both patients and medical providers. Many…
Morning Headlines 1/15/21
Health and technology leaders announce the Vaccination Credential Initiative, which hopes to provide digital access to COVID-19 vaccination records using the open SMART Health Cards specification.
Healthcare Specific AI Platform Lumiata Raises Series B Funding
Lumiata – which applies AI to 120 million patient records to predict patient outcomes, clinical costs, and risks for providers and payers – raises $14 million in a Series B funding round.
Healthtech firm Accolade is buying telemedicine start-up 2nd.MD for $460 million, sources say
Health benefits navigation company Accolade acquires 2nd.MD for $460 million to offer its users easier access to second opinions.
Provider and resource scheduling system vendor QGenda acquires Shift Admin, which offers shift-based specialty scheduling for emergency medicine, urgent care, and hospital medicine.
It will be interesting to see how those (such as myself) who participated in a vaccine clinical trial will be treated once vaccinations become required for travel, etc. I was unblinded from my AZ trial after my second dose and confirmed to have received the ‘real deal’.
I declined the Pfizer vaccine through my organization as a result, but am increasingly worried that although I may have done my part to preserve some integrity of the trial data that I will unfortunately have to get it anyway to fill a requirement of an airline, sporting event, etc down the road.